Cargando…

P1687: THROMBOEMBOLISM IN COVID-19 PATIENTS ON ECMO

Detalles Bibliográficos
Autores principales:	Jones, C., Chen, K., Cheng, G., Narendran, V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429578/ http://dx.doi.org/10.1097/01.HS9.0000849604.26850.08

Ejemplares similares

P1687: LIFE AFTER CAR T-CELLS: DO PATIENTS RECOVER A NORMAL LIFE?
por: Perthus, Alya, et al.
Publicado: (2023)

Case Series: The Coexistence of Thrombocytopenia and Thromboembolism in COVID-19 Patients on ECMO: A Case Series and Literature Review
por: Jones, Can, et al.
Publicado: (2021)

PB2303: THROMBOCYTOPENIA IN COVID-19 PATIENTS ON ECMO SUPPORT
por: Jones, C., et al.
Publicado: (2022)

1687P Oncologists knowledge, attitude and practice in COVID-19 pandemic and its negative impact on them: An international study
por: Jazieh, A.R., et al.
Publicado: (2020)

The evolution of dynamics vibration theory from 1687 to 1742
por: Cannon, John T, et al.
Publicado: (1981)

1687. Omadacycline in Female Adults With Acute Pyelonephritis: Results from a Randomized, Double-Blind, Adaptive Phase 2 Study
por: Overcash, J Scott, et al.
Publicado: (2020)

Paper bodies: a catalogue of anatomical fugitive sheets 1538-1687.
por: Carlino, A.
Publicado: (1999)

Long term outcome after respiratory ecmo and length of ecmo treatment
por: Kalzén, H, et al.
Publicado: (2015)

Outcomes of Thromboembolism in COVID-19 Cancer Patients Vs Non-Cancer Patients
por: Jones, Can, et al.
Publicado: (2022)

1687. High-Rates of Candida auris Carriage and Co-Colonization with Multidrug-Resistant Organisms (MDROs)
por: Barza, Ruby, et al.
Publicado: (2019)

Successful approach for emergent consent for ECMO research
por: Board, J, et al.
Publicado: (2015)

Determination of brain death for adult patients with ECMO
por: Ceylan, I, et al.
Publicado: (2015)

1687. Unprecedented Outbreak of Invasive group A Streptococcus Infections in Children - Colorado, October 2022 to March 2023
por: Ho, Erin C, et al.
Publicado: (2023)

P1691: COMPARISON OF IMPROVE, MODIFIED IMPROVE, IMPROVEDD AND PADUA RISK SCORES FOR VENOUS THROMBOEMBOLISM PREDICTION IN HOSPITALIZED COVID-19 PATIENTS
por: Lucijanic, M., et al.
Publicado: (2022)

Sextons' day books for 1685-1687 and 1694-1703 from the parish of St. Martin-in-the-Fields, London.
por: Forbes, T. R.
Publicado: (1973)

P1675: POST-HOSPITAL DISCHARGE EVALUATION OF COVID-19 SURVIVORS WHO SUFFERED ACUTE VENOUS THROMBOEMBOLISM (VTE) DURING HOSPITALIZATION: THE BERGAMO EXPERIENCE
por: Ambaglio, C., et al.
Publicado: (2022)

Cytokine adsorption and ECMO in patients with COVID-19
por: Rybalko, Andrey, et al.
Publicado: (2021)

PO-21 Incidence of venous thromboembolism events in outpatients with cancer and COVID-19.
por: Gutiérrez Ortiz de la Tabla, A., et al.
Publicado: (2021)

PO-57 Characteristics of venous thromboembolism following COVID-19 in Croatia
por: Barišić, B., et al.
Publicado: (2021)

Temperature Monitoring During Ecmo: An in Vitro Study
por: Mojoli, F, et al.
Publicado: (2015)

P1692: PREDICTIVE MODEL FOR VEIN THROMBOEMBOLIC EVENTS DEVELOPMENT IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Mitrovic, M., et al.
Publicado: (2022)

1687. Antimicrobial Activity of Ceftibuten-Avibactam against a Global Collection of Enterobacterales from Patients with Complicated Urinary Tract Infections (2021)
por: Sader, Helio S, et al.
Publicado: (2022)

Outcome of patients with congenital diaphragmatic hernia requiring ECMO: can we predict?
por: Tiruvoipati, R, et al.
Publicado: (2006)

Artificial Lung Gas Exchanges Depend On Ecmo Settings
por: Mojoli, F, et al.
Publicado: (2015)

Fibrinogen–Albumin-Ratio is an independent predictor of thromboembolic complications in patients undergoing VA-ECMO
por: Roth, Sebastian, et al.
Publicado: (2021)

ECMO for COVID-19 patients in Europe and Israel
por: Lorusso, Roberto, et al.
Publicado: (2021)

Cytokine adsorption and ECMO in patients with COVID-19
por: Nardelli, Pasquale, et al.
Publicado: (2021)

P1392: MACHINE LEARNING ALGORITHM AS A PROGNOSTIC TOOL FOR VENOUS THROMBOEMBOLISM IN ALLOGENIC TRANSPLANT PATIENTS
por: Deng, R.-X., et al.
Publicado: (2022)

P977: THE VENOUS THROMBOEMBOLISM RISK ASSESMENT MODELS IN MULTIPLE MYELOMA
por: Alp Kirkizlar, Tugcan, et al.
Publicado: (2023)

ECMO in nonintubated patients as a bridge to lung transplant: our experience
por: Chierichetti, M, et al.
Publicado: (2012)

P1554: INCREASED PREVALENCE OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE I
por: Asleh, M., et al.
Publicado: (2022)

No Difference in Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations
por: Houghton, Damon E., et al.
Publicado: (2022)

308. Secondary Infections in Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) for Severe Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 Pneumonia (PNA)
por: Rivosecchi, Ryan, et al.
Publicado: (2021)

Nowhere else to turn? building a case for equity of access to VV ECMO in the UK for complex multi-system patients
por: Loveridge, R, et al.
Publicado: (2015)

Blood Product Utilization in Patients With COVID-19 on ECMO
por: George, Timothy J., et al.
Publicado: (2022)

Awake ECMO and mobilizing patients on ECMO
por: Haji, Jumana Yusuf, et al.
Publicado: (2021)

292. Antibiotic Use Is Increased in Patients with Acute Respiratory Distress Syndrome (ARDS) Requiring Extracorporeal Membrane Oxygenation (ECMO) due to COVID-19 Compared with Influenza
por: Alex Viehman, J, et al.
Publicado: (2021)

P1641: RECURRENT VENOUS THROMBOEMBOLISMS AND ANTICOAGULATION COMPLICATIONS; A PROSPECTIVE STUDY.
por: Nasibov, Teymur, et al.
Publicado: (2023)

COVID-19 ECMO Myths Busted
por: Sharma, Amita, et al.
Publicado: (2020)

ECMO for ARDS due to COVID-19
por: Ñamendys-Silva, Silvio A.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1dqjitk3u8ehclq7oko7qeaior